Bionano Genomics, Inc. (BNGO)

USD 2.83

(-4.07%)

Total Assets Summary of Bionano Genomics, Inc.

  • Bionano Genomics, Inc.'s latest annual total assets in 2023 was 214.4 Million USD , down -30.28% from previous year.
  • Bionano Genomics, Inc.'s latest quarterly total assets in 2024 Q2 was 129.36 Million USD , down -18.12% from previous quarter.
  • Bionano Genomics, Inc. reported annual total assets of 307.5 Million USD in 2022, down -18.46% from previous year.
  • Bionano Genomics, Inc. reported annual total assets of 377.1 Million USD in 2021, up 523.83% from previous year.
  • Bionano Genomics, Inc. reported quarterly total assets of 157.99 Million USD for 2024 Q1, down -26.31% from previous quarter.
  • Bionano Genomics, Inc. reported quarterly total assets of 181.9 Million USD for 2023 Q3, down -32.97% from previous quarter.

Annual Total Assets Chart of Bionano Genomics, Inc. (2023 - 2016)

Historical Annual Total Assets of Bionano Genomics, Inc. (2023 - 2016)

Year Total Assets Total Assets Growth
2023 214.4 Million USD -30.28%
2022 307.5 Million USD -18.46%
2021 377.1 Million USD 523.83%
2020 60.44 Million USD 100.11%
2019 30.2 Million USD 21.79%
2018 24.8 Million USD 144.48%
2017 10.14 Million USD -31.39%
2016 14.78 Million USD 0.0%

Peer Total Assets Comparison of Bionano Genomics, Inc.

Name Total Assets Total Assets Difference
Aclaris Therapeutics, Inc. 197.4 Million USD -8.611%
Applied DNA Sciences, Inc. 13.65 Million USD -1470.544%
Aspira Women's Health Inc. 6.26 Million USD -3323.89%
Biodesix, Inc. 99.09 Million USD -116.36%
BioNexus Gene Lab Corp. 11.39 Million USD -1780.771%
bioAffinity Technologies, Inc. 8.22 Million USD -2507.829%
bioAffinity Technologies, Inc. 8.22 Million USD -2507.829%
CareDx, Inc 484.61 Million USD 55.758%
Check-Cap Ltd. 25.01 Million USD -757.033%
Castle Biosciences, Inc. 477.81 Million USD 55.128%
DarioHealth Corp. 96.38 Million USD -122.436%
Exact Sciences Corporation 6.47 Billion USD 96.687%
Fulgent Genetics, Inc. 1.27 Billion USD 83.159%
Guardant Health, Inc. 1.78 Billion USD 87.998%
ICON Public Limited Company 16.98 Billion USD 98.738%
IDEXX Laboratories, Inc. 3.25 Billion USD 93.423%
Illumina, Inc. 10.11 Billion USD 97.879%
Intelligent Bio Solutions Inc. 13.77 Million USD -1456.036%
iSpecimen Inc. 15.81 Million USD -1255.346%
Standard BioTools Inc. 323.06 Million USD 33.635%
MDxHealth SA 129.13 Million USD -66.035%
23andMe Holding Co. 395.16 Million USD 45.743%
Medpace Holdings, Inc. 1.65 Billion USD 87.059%
Myriad Genetics, Inc. 1.19 Billion USD 82.114%
Mainz Biomed B.V. 15.4 Million USD -1291.418%
ENDRA Life Sciences Inc. 6.75 Million USD -3074.406%
NeoGenomics, Inc. 1.68 Billion USD 87.247%
Neogen Corporation 4.58 Billion USD 95.323%
Inotiv, Inc. 856.53 Million USD 74.968%
Natera, Inc. 1.45 Billion USD 85.286%
OpGen, Inc. 1.88 Million USD -11290.69%
OPKO Health, Inc. 2.01 Billion USD 89.342%
Psychemedics Corporation 13.27 Million USD -1515.705%
Prenetics Global Limited 254.17 Million USD 15.646%
Prenetics Global Limited 254.17 Million USD 15.646%
Precipio, Inc. 18.1 Million USD -1084.487%
Personalis, Inc. 225.09 Million USD 4.751%
RadNet, Inc. 2.88 Billion USD 92.573%
Sera Prognostics, Inc. 95.44 Million USD -124.646%
Sotera Health Company 3.13 Billion USD 93.151%
Neuronetics, Inc. 115.83 Million USD -85.101%
Star Equity Holdings, Inc. 86.97 Million USD -146.515%
Star Equity Holdings, Inc. 86.97 Million USD -146.515%
Trinity Biotech plc 59.43 Million USD -260.737%
T2 Biosystems, Inc. 34.79 Million USD -516.157%
Twist Bioscience Corporation 776.4 Million USD 72.385%
Exagen Inc. 56.94 Million USD -276.517%